Tag: biosimilars
Future of Global Generic Markets: Key Predictions and Trends for 2025-2030
Explore the future of global generic drug markets with key predictions for 2025-2030. Learn about growth drivers, challenges, regional trends, and how biosimilars are reshaping affordable healthcare.
Lot-to-Lot Variability in Biologics and Biosimilars: What You Need to Know
Lot-to-lot variability is a natural part of biologics and biosimilars due to their complex manufacturing. Unlike generics, these drugs aren't identical between batches - but they're rigorously tested to ensure safety and effectiveness.
How Generic Medicines Save the U.S. Healthcare System Trillions
Generic and biosimilar drugs saved the U.S. healthcare system $467 billion in 2024 alone, with $3.4 trillion saved over the past decade. Learn how these affordable medications cut costs, who benefits most, and why barriers still exist.
Future Approaches to Changing Perceptions of Generic Drugs
Despite being just as effective as brand-name drugs, generic medications still face distrust. Learn how science, transparency, and better communication are changing public perception-and why it matters for affordable healthcare.